Table 5.
Prognostic factors for DSS, MFS, and LRFS of extremity and trunk sarcomas
| Prognostic factor | Reference | HR (95% CI) | P |
|---|---|---|---|
| DSS | |||
| Size > 5 cm | Size ≤ 5 cm | 2.39 (1.39–4.11) | 0.002 |
| FNCLCC 2 | FNCLCC 1 | 5.58 (1.30–23.91) | 0.020 |
| FNCLCC 3 | FNCLCC 1 | 6.47 (1.55–26.94) | 0.010 |
| UE with ReT | PE | 2.02 (1.25–3.26) | 0.004 |
| MFS | |||
| Size > 5 cm | Size ≤ 5 cm | 1.86 (1.18–2.93) | 0.007 |
| FNCLCC 3 | FNCLCC 1 | 2.92 (1.33–6.40) | 0.008 |
| Deep location | Superficial location | 1.74 (1.03–2.95) | 0.040 |
| UE with ReT | PE | 1.62 (1.05–2.51) | 0.030 |
| LRFS | |||
| UE without ReT | PE | 0.11 (0.02–0.79) | 0.028 |
| UE with ReT | PE | 1.94 (1.05–3.59) | 0.034 |
DSS, Disease‐specific survival; MFS, Metastasis‐free survival; LRFS, Local‐recurrence‐free survival; HR, Hazard ratio; CI, Confidence interval; FNCLCC, Fédération Nationale des Centres de Lutte le Cancer; UE, Unplanned excision; ReT, Residual tumor; PE, Planned excision.